Citation: Mh. Losso et al., A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4(+) cell counts >=350/mm(3) (vol 181, pg 1614, 2000), J INFEC DIS, 181(6), 2000, pp. 2122-2122
Authors:
Losso, MH
Belloso, WH
Emery, S
Benetucci, JA
Cahn, PE
Lasala, MC
Lopardo, G
Salomon, H
Saracco, M
Nelson, E
Law, MG
Davey, RT
Allende, MC
Lane, HC
Citation: Mh. Losso et al., A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4(+) cell counts >=350/mm(3), J INFEC DIS, 181(5), 2000, pp. 1614-1621